EP Patent

EP0773034A1 — Biodegradable in-situ forming implants

Assigned to Tolmar Therapeutics Inc · Expires 1997-05-14 · 29y expired

What this patent protects

A biodegradable thermosetting polymer system is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. The thermosetting system comprises mix…

USPTO Abstract

A biodegradable thermosetting polymer system is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. The thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. The system provides a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body.

Drugs covered by this patent

Patent Metadata

Patent number
EP0773034A1
Jurisdiction
EP
Classification
Expires
1997-05-14
Drug substance claim
No
Drug product claim
No
Assignee
Tolmar Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.